| |
|
Form Serial Number: |
CS20261005E00022 |
| 1.
Date of relevant event: |
29/09/2026
(dd/mm/yyyy)
|
| 2.
Date when the substantial shareholder becomes aware of the relevant event / interest in the shares (if later): |
(dd/mm/yyyy)
|
| 3.
Stock code: |
02186 |
| 4.
Name of listed corporation: |
Luye Pharma Group Ltd. |
| 5.
Class of shares: |
Ordinary Shares |
| 6.
Number of issued shares in class: |
3,994,515,953 |
| 7.
Name of substantial shareholder: |
Ginkgo (PTC) Limited |
| 8.
Registered office: |
Helvetia Court, South Esplanade, St Peter Port, Guernsey |
| 9.
Principal place of business in Hong Kong: |
N/A |
| 15.
Exchange on which listed: |
|
| 16.
Name of listed parent and exchange on which parent is listed: |
|
|
| 17.
Details of relevant event: |
|
|
Brief description of relevant event
|
Capacity in which shares were/are held
|
Number of shares bought/sold or involved |
Currency of transaction |
On Exchange
|
Off Exchange
|
| Before relevant event
|
After relevant event
|
Highest price (per share)
|
Average price (per share)
|
Average consideration (per share)
|
Nature of consideration
|
|
Long position |
|
|
|
|
|
|
|
|
|
| Short position |
| 1503 | You ceased to have a short position of 1% or more in the shares, or the percentage level of your short position in such shares decreased because:
any other event (you must briefly describe the relevant event in the Supplementary Information box) |
|
|
|
8,544,000 |
|
|
|
|
|
|
|
| 18.
Total shares immediately before the relevant event: |
| | Total number of shares | Percentage figure (%) |
| Long position | 1,246,108,703 | 31.20 |
| Short position | 212,229,950 | 5.31 |
|
|
| 19.
Total shares immediately after the relevant event: |
| | Total number of shares | Percentage figure (%) |
| Long position | 1,246,108,703 | 31.20 |
| Short position | 203,685,950 | 5.10 |
|
|
| 20.
Capacity in which interests disclosed in Box 19 are held: |
| Capacity code | Number of shares |
| | Long position | 1,246,108,703 | | Short position | 203,685,950 |
|
|
|
|
|
| 21.
Further information in respect of derivative interests: |
| Derivatives code | Number of shares |
| 4105 | Unlisted derivatives - Physically settled |
| | Short position | 203,685,950 |
|
|
|
| 22.
Further information in relation to interests of corporations controlled by substantial shareholder: |
| Name of controlled corporation | Address and place of incorporation | Name of controlling person | % control | Direct interest (Y/N) | Number of shares |
| Nelumbo Investments Limited | Helvetia Court, South Esplanade, St Peter Port, Guernsey (Guernsey) | Ginkgo (PTC) Limited | 100.00 | N | | Long position | 1,246,108,703 | | Short position | 203,685,950 |
|
| Luye Life Sciences Group Ltd | Clarendon House, 2 Church Street, Hamilton HM 11, Bermuda (Bermuda) | Nelumbo Investments Limited | 70.00 | N | | Long position | 1,246,108,703 | | Short position | 203,685,950 |
|
| Luye Pharma Holdings Ltd. | Cricket Square, Hutchins Drive, PO Box 2681, Grand Cayman, KY1-1111, Cayman Islands (Cayman Islands) | Luye Life Sciences Group Ltd | 100.00 | N | | Long position | 1,246,108,703 | | Short position | 203,685,950 |
|
| LuYe Pharmaceutical International Co., Ltd. | PO Box 309, Ugland House, Grand Cayman, KY1-1104, Cayman Islands (Cayman Islands) | Luye Pharma Holdings Ltd. | 100.00 | N | | Long position | 1,246,108,703 | | Short position | 203,685,950 |
|
| LuYe Pharmaceutical Investment Co., Ltd. | PO Box 309, Ugland House, Grand Cayman, KY1-1104, Cayman Islands (Cayman Islands) | LuYe Pharmaceutical International Co., Ltd. | 100.00 | Y | | Long position | 1,246,108,703 | | Short position | 203,685,950 |
|
|
|
|
| 23.
Further information in relation to interests held by substantial shareholder jointly with another person: |
| Name of joint shareholder | Address | Number of shares |
| | |
|
|
| 24.
Further information from a trustee, a beneficiary of a trust, or a person who set up a discretionary trust: |
| Names of trust | Address | Status code | Number of shares |
| | | |
|
|
| 25.
Further information from a party to an agreement under Section 317 (Please see Notes for further information required): |
| Names of other parties | Address | Number of shares |
| | |
| Total number of shares in which a substantial shareholder is interested under sections 317 and 318 | |
|
|
| 26.
Details of person(s) in accordance with whose directions the substantial shareholder or its directors are accustomed to act: |
| Names | Address | Relationship Code | Percentage (%) |
| | | |
|
| |
| 27.
Supplementary information: |
The short position before and after the relevant event has been updated.
|
| 28.
Log/Serial Number of the previous form: |
|
| 29.
Number of concert party document(s) under section 317 attached/uploaded: |
|
|
Date of filing this Form 2: |
05/10/2026
(dd/mm/yyyy)
|
|
|
|
|